Skip to content

A prospective, single-center, randomized controlled study of the effect of high or low ligation of the inferior mesenteric artery on postoperative bowel function in patients undergoing laparoscopic total mesangial resection for rectal cancer

A prospective, single-center, randomized controlled study of the effect of high or low ligation of the inferior mesenteric artery on postoperative bowel function in patients undergoing laparoscopic total mesangial resection for rectal cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100042347
Enrollment
Unknown
Registered
2021-01-19
Start date
2021-03-01
Completion date
Unknown
Last updated
2022-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal cancer

Interventions

Experimental group:Lower ligation of the inferior mesenteric artery
Control group:Higher ligation of the inferior mesenteric artery

Sponsors

The First Affiliated Hospital of Air Force Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Subjects aged 18-75 years; 2. Adenocarcinoma of the rectum was confirmed by pathology; 3. Electronic hard mirror examination and/or MR assessment of tumor within 10cm from anus; 4. Laparoscopic radical anterior resection of rectal cancer is proposed; 5. ECOG (Eastern Cooperative Oncology Group) determined the clinical status as 0-2; 6. Sign the consent form.

Exclusion criteria

Exclusion criteria: 1. Distant metastasis of tumor; 2. Violation of the principle of randomization or ileostomy; 3. A history of intractable constipation or inflammatory bowel disease; 4. Patients with severe cardiovascular and cerebrovascular, liver and kidney diseases and abnormal liver and kidney functions; 5. Rectal anastomotic stenosis was followed up after operation.

Design outcomes

Primary

MeasureTime frame
Bowel function;3 year progression-free survival (PFS);

Secondary

MeasureTime frame
3 year overall survival (OS);

Countries

China

Contacts

Public ContactJianyong Zheng

The First Affiliated Hospital of Air Force Medical University

zhengjy68@126.com+86 13891385899

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026